These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 19084086

  • 41. [Treatment of dyslipidemia in clinical practice].
    Paragh G, Harangi M.
    Orv Hetil; 2006 Mar 05; 147(9):389-94. PubMed ID: 16619956
    [Abstract] [Full Text] [Related]

  • 42. Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia.
    Wierzbicki AS.
    Curr Opin Cardiol; 2009 Jul 05; 24(4):372-9. PubMed ID: 19424060
    [Abstract] [Full Text] [Related]

  • 43. Combination therapy with statins and omega-3 fatty acids.
    Nambi V, Ballantyne CM.
    Am J Cardiol; 2006 Aug 21; 98(4A):34i-38i. PubMed ID: 16919515
    [Abstract] [Full Text] [Related]

  • 44. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R, Goldberg AC.
    Endocrinol Metab Clin North Am; 2009 Mar 21; 38(1):79-97. PubMed ID: 19217513
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk.
    Stalenhoef AF, Davidson MH, Robinson JG, Burgess T, Duttlinger-Maddux R, Kallend D, Goldberg AC, Bays H.
    Diabetes Obes Metab; 2012 Jan 21; 14(1):30-9. PubMed ID: 21819519
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials.
    Taylor AJ.
    Am J Cardiol; 2008 Apr 17; 101(8A):36B-43B. PubMed ID: 18375240
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome.
    Deedwania PC, Hunninghake DB, Bays H.
    Am J Cardiol; 2004 Jun 03; 93(11A):18C-26C. PubMed ID: 15178513
    [Abstract] [Full Text] [Related]

  • 52. Treatment of high-risk older persons with lipid-lowering drug therapy.
    Aronow WS.
    Am J Ther; 2008 Jun 03; 15(2):102-7. PubMed ID: 18356628
    [Abstract] [Full Text] [Related]

  • 53. Monotherapy vs combination therapy for dyslipidemia in the elderly.
    Shepherd J.
    Am J Geriatr Cardiol; 2008 Jun 03; 17(2):108-13. PubMed ID: 18326949
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK, Juenger C, Jannowitz C, Karmann B, Senges J, Bestehorn K.
    Eur J Cardiovasc Prev Rehabil; 2009 Aug 03; 16(4):438-44. PubMed ID: 19369876
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.